More than one approach to generating value.

At Ligand, we seek to identify high-value, risk-mitigated biopharmaceutical assets. We take a systematic and disciplined approach to investing to create a diversified portfolio of programs that produce consistent and predictable revenue streams for our shareholders.

Investment Strategies

Asset Selection Criteria

  • Strong clinical differentiation
  • Addresses unmet need 
  • Solid patent protection
  • Time to market
  • Therapeutically agnostic

Asset Selection Criteria

Strong clinical differentiation

Addresses unmet need 

Solid patent protection

Within a few years from market

Therapeutically agnostic